TCG Crossover Management, LLC
Q4 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
43
- Value ($000)
$3,021,699
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001839948
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | $959.03M | 32 % | 7,111,596 | ||
COGENT BIOSCIENCES INC | COMM | 19240Q201 | $208.44M | 7 % | 5,868,162 | ||
CG ONCOLOGY INC | COMM | 156944100 | $152.39M | 5 % | 3,670,206 | ||
TANGO THERAPEUTICS INC | COMM | 87583X109 | $113.07M | 4 % | 12,762,094 | ||
CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | $107.2M | 4 % | 4,286,480 | ||
DYNE THERAPEUTICS INC | COMM | 26818M108 | $90.27M | 3 % | 4,615,144 | ||
RAPT THERAPEUTICS INC | COMM | 75382E208 | $87.47M | 3 % | 2,582,408 | ||
TYRA BIOSCIENCES INC | COMM | 90240B106 | $76.19M | 3 % | 2,898,103 | ||
AMYLYX PHARMACEUTICALS INC | COMM | 03237H101 | $75.43M | 3 % | 6,243,812 | ||
SAVARA INC | COMM | 805111101 | $74.54M | 3 % | 12,362,205 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100